Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA
Quang, V. Tran, Podvin, B., Desterke, C., Tarfi, S., Barathon, Q., Bouchra, B., Freynet, N., Parinet, V., Leclerc, M., Sébastien, M., Solary, E., Selimoglu-Buet, D., Duployez, N., Wagner-Ballon, O., Sloma, I.
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Bardet, Valérie, Wagner-Ballon, Orianne, Guy, Julien, Morvan, Céline, Debord, Camille, Trimoreau, Franck, Benayoun, Emmanuel, Chapuis, Nicolas, Freynet, Nicolas, Rossi, Cédric, Mathis, Stéphanie, Gourin, Marie-Pierre, Toma, Andréa, Béné, Marie C, Feuillard, Jean, Guérin, Estelle
Published in Haematologica (Roma) (01.04.2015)
Published in Haematologica (Roma) (01.04.2015)
Get full text
Journal Article